基本信息
views: 11
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
No content for now
Research Interests
Papers共 58 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Sawsan M. Kurdi,Ahmad Alamer, Aya Albaggal, Marwa Alsuwaiket,Fawaz M. Alotaibi,Ibrahim M. Asiri,Dhfer M. Alshayban,Mohammed M. Alsultan,Bashayer Alshehail,Bassem A. Almalki,Dania Hussein,Mansour M. Alotaibi,
JOURNAL OF CLINICAL MEDICINEno. 2 (2024): 419
SAUDI PHARMACEUTICAL JOURNALno. 2 (2024): 101952-101952
Abdulaziz Alsalem,Mohammed M. Alsultan, Faisal Alqarni, Abdullah Almangour, Lolwa Alsharekh, Saleem Alenazi, Saleh Alzahrani, Raghad A. Almanqour, Abdullah Alazmi,Abdullah Alzahrani
FRONTIERS IN PHARMACOLOGY (2024): 1366439-1366439
Saudi Pharmaceutical Journalno. 1 (2024): 101924-101924
Fawaz M. Alotaibi, Zainab M. Bukhamsin, Alanoud Nasser Alsharafaa,Ibrahim M. Asiri,Sawsan M. Kurdi,Dhafer M. Alshayban,Mohammed M. Alsultan,Bassem A. Almalki, Wafa Ali Alzlaiq,Mansour M. Alotaibi
HEALTHCAREno. 22 (2023): 2936-2936
SAUDI PHARMACEUTICAL JOURNALno. 3 (2023): 453-461
Mohammed M. Alsultan, Rabab Alamer, Fatimah Alammar,Wafa Alzlaiq,Abdullah K. Alahmari,Ziyad S. Almalki,Faisal Alqarni,Dhfer M. Alshayban,Fawaz M. Alotaibi,Ibrahim M. Asiri,Fahad Alsultan,Sawsan M. Kurdi,
SAUDI PHARMACEUTICAL JOURNALno. 12 (2023): 101875-101875
Mohammed M. Alsultan,Abdullah K. Alahmari, Mansour A. Mahmoud,Ziyad S. Almalki,Wafa Alzlaiq,Faisal Alqarni,Fahad Alsultan,Nehad Jaser Ahmed,Ahmed O. Alenazi, Lucas Scharf,Jeff Jianfei Guo
FRONTIERS IN PHARMACOLOGY (2023): 1276491-1276491
Fowad Khurshid, Fahad Alharbi, Abdulrahman Almohydib, Shatha Ibn Malik,Hussain A. Al-Omar,Mohammed S. Alsultan,Abdlatif Alghaiheb
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn